Profound Medical Corp. Files 8-K on Operations and Other Events
Ticker: PROF · Form: 8-K · Filed: Jan 8, 2025 · CIK: 1628808
| Field | Detail |
|---|---|
| Company | Profound Medical Corp. (PROF) |
| Form Type | 8-K |
| Filed Date | Jan 8, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: operations, financial-condition, filing-update
Related Tickers: PMED
TL;DR
PMED filed an 8-K, expect updates on financials and other news soon.
AI Summary
Profound Medical Corp. filed an 8-K on January 8, 2025, reporting on its results of operations and financial condition, as well as other events. The filing does not contain specific financial figures or details about the "other events" at this time.
Why It Matters
This 8-K filing signals that Profound Medical Corp. is providing updates on its financial performance and potentially significant corporate developments to the public.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting operational and financial updates, with no immediate negative or positive financial disclosures.
Key Players & Entities
- Profound Medical Corp. (company) — Registrant
- January 8, 2025 (date) — Date of Report
- 2400 Skymark Avenue, Unit 6 Mississauga , Ontario , Canada L4W 5K5 (address) — Principal Executive Offices
FAQ
What specific "Results of Operations and Financial Condition" are being reported?
The filing indicates that results of operations and financial condition are being reported, but the specific details, figures, or financial statements are not included in this initial 8-K filing document.
What are the "Other Events" that Profound Medical Corp. is reporting?
The filing lists "Other Events" as a category for reporting, but the nature or details of these events are not specified within the provided text.
When was this 8-K report filed?
This 8-K report was filed on January 8, 2025.
What is the principal executive office address for Profound Medical Corp.?
The principal executive office address is 2400 Skymark Avenue, Unit 6, Mississauga, Ontario, Canada L4W 5K5.
What is the Commission File Number for Profound Medical Corp.?
The Commission File Number for Profound Medical Corp. is 001-39032.
Filing Stats: 513 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2025-01-08 07:45:33
Filing Documents
- f8k_010825.htm (8-K) — 15KB
- exh_991.htm (EX-99.1) — 11KB
- 0001171843-25-000114.txt ( ) — 224KB
- gnw-20190101.xsd (EX-101.SCH) — 3KB
- gnw-20190101_def.xml (EX-101.DEF) — 25KB
- gnw-20190101_lab.xml (EX-101.LAB) — 33KB
- gnw-20190101_pre.xml (EX-101.PRE) — 22KB
- f8k_010825_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On January 8, 2025, Profound Medical Corp. issued a press release to announce its preliminary unaudited revenues for the quarter and year ended December 31, 2024. A copy of the press release is furnished as Exhibit 99.1. The information in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed to be "filed" for purposes of Section 18, of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities under that section, and shall not be deemed to be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
01. Other Events
Item 8.01. Other Events. (d) Exhibits Exhibit No. Description 99.1 Press Release dated January 8, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PROFOUND MEDICAL CORP. Date: January 8, 2025 By: /s/ Rashed Dewan Rashed Dewan Chief Financial Officer